IONS stock forecast
Our latest prediction for Ionis Pharmaceuticals, Inc.'s stock price was made on the Jan. 2, 2020 when the stock price was at 60.89$.
In the short term (2weeks), IONS's stock price should underperform the market by -3.14%. During that period the price should oscillate between -6.52% and +4.88%.
In the medium term (3months), IONS's stock price should underperform the market by -8.63%. During that period the price should oscillate between -22.26% and +13.32%.Get email alerts
About Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.
At the moment the company generates 821M USD in revenues.
On its last earning announcement, the company reported a profit of 3.19$ per share.
The book value per share is 5.07$
Three months stock forecastJan. 2, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|